Navigation Links
Ellman's Pelleve™ Wrinkle Reduction System featured in "Sexy Eyes" segment on The Doctors
Date:11/28/2011

OCEANSIDE, N.Y., Nov. 28, 2011 /PRNewswire/ -- The Pelleve™ Wrinkle Reduction System was featured in a live demonstration on The Doctors on November 17th. Top dermatologist Dr. Ava Shamban of Santa Monica, CA performed the treatment, giving the audience and viewers a first-hand look at how Pelleve works. The treatment produced noticeable results in under an hour—less time than it takes to watch the show.

A revolutionary, non-ablative skin tightening system, Pelleve uses radiofrequency to provide a virtually pain free wrinkle reduction treatment that feels like a warm, relaxing massage. Although it is designed for use over the entire face, Dr Shamban demonstrated how Pelleve is especially good for treating around the eyes, giving brows a lift. Pelleve works by slowly heating the deep layers of the skin, creating new collagen, plumping up wrinkles, firming and tightening skin. There is no downtime and results last up to six months.

The hosts on The Doctors called Pelleve an "extremely exciting" new technology and a good way to "recapture a bit of your youth." Dr. Shamban says that a benefit of the device is that it delivers instant results, and though three sessions may be needed, the results improve with each consecutive treatment as Pelleve continues to stimulate the growth of more collagen. In the program, the patient, Sharon, experienced a 2mm lift in her brows, as well as in her eyelids.

To view The Doctor segment featuring Pelleve and view before and after images:
http://www.thedoctorstv.com/videolib/init/5298

About Ellman International

Founded in 1959, Ellman® International, Inc., a New York based manufacturer of devices for surgical and aesthetic procedures, remains recognized today as a pioneer in the development of specialized radiofrequency technology for precision cutting, coagulating, and tissue ablation in physician's offices and clinics. Ellman has a wide range of products that are used in aesthetic, surgical, dental and veterinary medicine in over 60 countries.  In 2009, the company leveraged the versatility of its unique radiofrequency platform to introduce the Pelleve™ Wrinkle Reduction System.  Pelleve is a revolutionary skin tightening system for non-ablative skin rejuvenation that can be performed in an hour or less, is virtually pain free and has minimal downtime for the patient.  Ellman introduced the Ellumine System, the latest innovation for fractional CO2 skin resurfacing, in late 2011.

For more information, visit www.ellman.com, www.pelleve.com and www.ellumine.com.

Find Pelleve at:
Facebook.com/pelleve
twitter.com/officialpelleve
twitter.com/pelleveskin

 


'/>"/>
SOURCE Ellman International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies
2. Looking Older Than You Are May Have Little to Do With Wrinkles
3. Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
4. Fibrocell Science, Inc. Receives FDA Complete Response Letter Regarding azficel-T for Wrinkles
5. NIST scientists address wrinkles in transparent film development
6. Ironing out the causes of wrinkles
7. Graphene: What can go wrong? new studies point to wrinkles, process contaminants
8. Nanowrinkles, nanofolds yield strange hidden channels
9. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
10. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
11. Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from ... believe could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving ... to read it now. , Biomarkers are components in the blood, tissue ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
Breaking Biology News(10 mins):